GC–MS based comparative metabolomic analysis of MCF-7 and MDA-MB-231 cancer cells treated with Tamoxifen and/or Paclitaxel
Author:
Funder
University of Sharjah
Publisher
Elsevier BV
Subject
Biochemistry,Biophysics
Reference41 articles.
1. In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis;Bulfoni;Breast Cancer Res.,2016
2. Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer;Dowsett;Endocr. Relat. Cancer,2001
3. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy;Nguyen;J. Clin. Oncol.,2008
4. Re-appraisal of estrogen receptor negative/progesterone receptor positive (ER-/PR+) breast cancer phenotype: true subtype or technical artefact?;Foley;Pathol. Oncol. Res.,2018
5. Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials;van Mackelenbergh;Breast Cancer Res. Treat.,2018
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The potential role of hot flashes treatment strategies and regorafenib combinations in breast cancer therapy via co-drug loaded polymeric nanoparticles;Journal of Drug Delivery Science and Technology;2024-09
2. Comparative metabolomics of MCF-7 and MCF-7/TAMR identifies potential metabolic pathways in tamoxifen resistant breast cancer cells;American Journal of Translational Research;2024
3. Recent Contributions of Mass Spectrometry-Based “Omics” in the Studies of Breast Cancer;Chemical Research in Toxicology;2023-11-27
4. Photodynamic therapy with zinc phthalocyanine enhances the anti-cancer effect of tamoxifen in breast cancer cell line: Promising combination treatment against triple-negative breast cancer?;Photodiagnosis and Photodynamic Therapy;2023-03
5. KODAMA exploratory analysis in metabolic phenotyping;Frontiers in Molecular Biosciences;2023-01-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3